Breaking News Instant updates and real-time market news.

RTN

Raytheon

$202.42

3.6 (1.81%)

, UBER

Uber

$34.50

1.26 (3.79%)

10:12
09/16/19
09/16
10:12
09/16/19
10:12

Fly Intel: Top five analyst upgrades

Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Raytheon (RTN) upgraded to Overweight from Neutral at JPMorgan with analyst Seth Seifman saying the stock's outperformance thus far in September is a sign of increasing investor confidence in the outlook for Raytheon and for the United Technologies (UTX) combination, along with some mean reversion. 2. Uber (UBER) and Lyft (LYFT) upgraded to Buy from Hold at HSBC. 3. Schlumberger (SLB) upgraded to Overweight from Equal Weight at Barclays with analyst J. David Anderson saying new CEO Olivier Le Peuch "hit all the right notes" as he repositions the company to succeed in a lower growth environment. 4. RE/MAX Holdings (RMAX) upgraded to Outperform from Market Perform at JMP Securities. 5. Esperion (ESPR) upgraded to Neutral from Sell at Goldman Sachs with analyst Paul Choi saying he now sees less risk of the launch performance of bempedoic acid disappointing over the intermediate term since 2019-2022 consensus revenue estimates have come down "meaningfully." This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

RTN

Raytheon

$202.42

3.6 (1.81%)

UBER

Uber

$34.50

1.26 (3.79%)

LYFT

Lyft

$48.27

2.17 (4.71%)

SLB

Schlumberger

$39.56

2.235 (5.99%)

RMAX

RE/MAX Holdings

$28.19

0.915 (3.35%)

ESPR

Esperion

$36.90

0.34 (0.93%)

  • 11

    Oct

  • 18

    Oct

  • 13

    Nov

RTN Raytheon
$202.42

3.6 (1.81%)

09/13/19
UBSW
09/13/19
NO CHANGE
Target $215
UBSW
Neutral
Raytheon price target raised to $215 from $205 at UBS
UBS analyst Myles Walton raised his price target on Raytheon to $215, saying that the next couple of months should clear up the remaining uncertainty around the company's outlook. The analyst expects the Lower Tier Air and Missile Defense Sensor, or LTAMDS, contract decision to be made in Q3, which would remove further risk about the performance of the company's Missile Defense System. Walton also keeps his Neutral rating on Raytheon.
09/16/19
JPMS
09/16/19
UPGRADE
Target $230
JPMS
Overweight
Raytheon upgraded to Overweight from Neutral at JPMorgan
JPMorgan analyst Seth Seifman upgraded Raytheon to Overweight from Neutral and raised his price target for the shares to $230 from $225.
09/16/19
JPMS
09/16/19
UPGRADE
Target $230
JPMS
Overweight
JPMorgan upgrades Raytheon to Overweight on increasing merger confidence
JPMorgan analyst Seth Seifman upgraded Raytheon (RTN) to Overweight from Neutral and raised his price target for the shares to $230 from $225. The stock's outperformance thus far in September is a sign of increasing investor confidence in the outlook for Raytheon and for the United Technologies (UTX) combination, along with some mean reversion, Seifman tells investors in a research note. With potential upside on both valuation and estimates, further increases in confidence point to a positive risk/reward dynamic for Raytheon shares, says the analyst.
09/16/19
WBLR
09/16/19
NO CHANGE
WBLR
Outperform
William Blair sees Raytheon comments as positive for AeroVironment approval
According to multiple media reports, Raytheon (RTN) this week at the DSEI defense conference in London indicated that it expects for U.S. Congress to soon allow it to sell its portable Coyote drone missile system to international customers, William Blair analyst Louie DiPalma told investors in a research note on Friday afternoon. The analyst believes this portends well for AeroVironment's similar quest to receive approval to sell its Switchblade portable missile system to international customers. He now expects AeroVironment to receive this approval by the end of calendar 2021, at the latest. International Switchblade sales could be worth $28 to $36 of equity value to AeroVironment, says DiPalma, who keeps an Overweight rating on the shares.
UBER Uber
$34.50

1.26 (3.79%)

09/16/19
HSBC
09/16/19
UPGRADE
Target $62
HSBC
Buy
HSBC upgrades Lyft and Uber to Buy despite cutting price targets
HSBC analyst Masha Kahn upgraded Lyft to Buy from Hold with a price target of $62, down from $67. Investor sentiment has turned "more sour" on ride-hailing stocks following large reported losses, regulatory headlines out of California and concerns around slowing growth, Kahn tells investors in a research note. However, with Lyft and Uber shares down 23% in the last three months, regulatory concerns are priced in, says the analyst, Further, Kahn continues to see "a lot of optionality" around product improvements for both Uber and Lyft. In addition, with 60% gross margins in the U.S. and over 70% internationally, the ride-hailing businesses of companies can reach profitability if both pull back on sales and marketing and leverage the fixed cost base, says the analyst.
09/16/19
HSBC
09/16/19
UPGRADE
HSBC
Buy
Uber upgraded to Buy from Hold at HSBC
09/12/19
09/12/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Peloton (PTON) initiated with a Neutral at DA Davidson. 2. Uber (UBER) initiated with a Hold due to valuation at Argus. 3. Carvana (CVNA) initiated with a Buy at Needham while CarGurus (CARG) and TrueCar (TRUE) initiated with a Hold. 4. Coupa Software (COUP) and Fiserv (FISV) initiated with a Buy at Canaccord. 5. Arvinas (ARVN) initiated with an Outperform at BMO Capital. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
09/16/19
HSBC
09/16/19
UPGRADE
Target $44
HSBC
Buy
HSBC upgrades Uber and Lyft to Buy amid 'more sour' investor sentiment
HSBC analyst Masha Kahn upgraded Uber Technologies (UBER) to Buy from Hold with a price target of $44, down from $49. The analyst this morning also upgraded Lyft (LYFT) to Buy from Hold. Investor sentiment has turned "more sour" on ride-hailing stocks following large reported losses, regulatory headlines out of California and concerns around slowing growth, Kahn tells investors in a research note. However, with Lyft and Uber shares down 23% in the last three months, regulatory concerns are priced in, says the analyst, Further, Kahn continues to see "a lot of optionality" around product improvements for both Uber and Lyft. In addition, with 60% gross margins in the U.S. and over 70% internationally, the ride-hailing businesses of companies can reach profitability if both pull back on sales and marketing and leverage the fixed cost base, says the analyst. Kahn also believes food delivery is a "free" option for Uber investors.
LYFT Lyft
$48.27

2.17 (4.71%)

09/16/19
HSBC
09/16/19
UPGRADE
HSBC
Buy
Lyft upgraded to Buy from Hold at HSBC
09/12/19
LOOP
09/12/19
NO CHANGE
LOOP
Lyft, Uber price targets lowered at Loop Capital on AB5 legislation in CA
Loop Capital analyst Jeffrey Kauffman lowered his price target on Uber to $48 from $54 and on Lyft to $52 from $60, saying the companies' long-term earnings power is being reduced with AB5 legislation in California moving forward while effectively turning its "gig workes" into W2 employees with guaranteed wages and benefits. The analyst believes that ultimately, the companies will reach a concession that raises costs and will be passed on to consumers through higher price, resulting in some "negative demand elasticity". Kauffman keeps his ratings on Uber at Buy and Lyft at Hold.
SLB Schlumberger
$39.56

2.235 (5.99%)

09/16/19
LEHM
09/16/19
UPGRADE
Target $50
LEHM
Overweight
Schlumberger upgraded to Overweight from Equal Weight at Barclays
Barclays analyst J. David Anderson upgraded Schlumberger to Overweight from Equal and raised his price target for the shares to $50 from $45.
09/16/19
LEHM
09/16/19
UPGRADE
Target $50
LEHM
Overweight
Barclays upgrades Schlumberger after new CEO 'hit all the right notes'
Barclays analyst J. David Anderson upgraded Schlumberger to Overweight from Equal and raised his price target for the shares to $50 from $45. New CEO Olivier Le Peuch "hit all the right notes" as he repositions the company to succeed in a lower growth environment, Anderson tells investors in a research note. The analyst believes Le Peuch addressed the Street's biggest concerns while also providing "bold, yet achievable" financial targets. Anderson thinks long-only investors will start to pay attention after gaining confidence in the new direction of Schlumberger. The company is now best positioned among the Big 3, says the analyst.
09/10/19
09/10/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. BHP Group (BHP) upgraded to Buy from Neutral at Goldman Sachs. 2. Marten Transport (MRTN) and Heartland Express (HTLD) upgraded to Overweight from Sector Weight at KeyBanc. 3. MercadoLibre (MELI) upgraded to Buy from Neutral at BTIG with analyst Marvin Fong saying the pullback in shares post-Argentina is overdone. 4. Schlumberger (SLB) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst Connor Lynagh saying that while the stock struggled over the past several years, its relative outlook is improving. 5. Boston Properties (BXP) upgraded to Equal Weight from Underweight at Morgan Stanley with analyst Vikram Malhotra saying valuations are more reasonable today in the New York City office real estate investment trust space following this year's underperformance. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/16/19
SBSH
09/16/19
NO CHANGE
SBSH
Nabors, Schlumberger, Halliburton have material operations in Saudi, says Citi
Following the attacks on Saudi Arabia, Citi analyst Scott Gruber expects "most if not all" of the Upstream Energy complex could see an uplift. However, Nabors Industries (NBR), Schlumberger (SLB), Halliburton (HAL) and Valaris (VAL) have material operations in Saudi and could see activity slow given the magnitude of the outage, Gruber tells investors in a research note.
RMAX RE/MAX Holdings
$28.19

0.915 (3.35%)

09/16/19
09/16/19
UPGRADE
Target $40

Outperform
RE/MAX Holdings upgraded to Outperform at JMP Securities on improving home sales
As previously reported, JMP Securities analyst Aaron Hecht upgraded RE/MAX Holdings to Outperform with a price target of $40. The analyst believes that the company can take advantage of improving existing home sales comps over the next 12 months, with added benefits coming from its "fully rolled out Booj operating platform and a positive margin impact from its Motto Mortgage business." Hecht adds that the current sentiment on RE/MAX has been low because of the negative trend in its owned agent count, stating that the benefits of the company's recent upfront investments in the business have "yet to be recognized."
09/16/19
JMPS
09/16/19
UPGRADE
Target $40
JMPS
Outperform
RE/MAX Holdings upgraded to Outperform from Market Perform at JMP Securities
JMP Securities analyst Aaron Hecht upgraded RE/MAX Holdings to Outperform from Market Perform with a $40 price target.
08/21/19
08/21/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. ServiceNow (NOW) upgraded to Buy from Hold at Stifel with analyst Tom Roderick saying his partner checks were "decidedly positive" in contract to investor concerns about a lackluster Q3 bookings outlook, which has weighed on shares since the Q2 call on July 24. 2. Emerald Expositions Events (EEX) upgraded to Buy from Neutral at Goldman Sachs with analyst Katherine Tait citing its 31% underperformance relative to the sector year-to-date, and added that it continues to be a "compelling take-out candidate, particularly considering other acquisitions in the sector in the last five years. 3. Public Storage (PSA) and Life Storage (LSI) upgraded to Neutral from Underperform at Baird. 4. On Deck Capital (ONDK) upgraded to Equal Weight from Underweight at Morgan Stanley with analyst James Faucette saying after a 57% decline in stock since the end of January, valuation is "more evenly" balancing its faster earnings growth with its relatively higher risk of incremental downward revisions. 5. RE/MAX Holdings (RMAX) and Redfin (RDFN) upgraded to Buy from Hold at Craig-Hallum. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/21/19
CHLM
08/21/19
UPGRADE
Target $35
CHLM
Buy
RE/MAX Holdings upgraded to Buy at Craig-Hallum
As previously reported, Craig-Hallum analyst Brad Berning upgraded RE/MAX Holdings to Buy from Hold as he believes the company is well-positioned for the increasing competition and digitalization of distribution channels that will enable consumers to demand greater service and drive the professionalization of the residential real estate agent industry. The analyst also believes housing market weaknesses should subside in the near-term, earnings expectations have been de-risked for his prior concerns about competition for agents and given an attractive valuation for a company he expects will be a long-term winner. Berning raised his price target on the shares to $35 from $30.
ESPR Esperion
$36.90

0.34 (0.93%)

06/27/19
JMPS
06/27/19
NO CHANGE
Target $153
JMPS
Outperform
Esperion funding deal with Oberland a positive, says JMP Securities
JMP Securities analyst Jason Butler said he views Esperion's funding transaction with Oberland Capital Management as a positive step for the company that provides it with optionality to optimize investment into bempedoic acid's commercial launch. The capped revenue-based funding agreement provides substantial immediate capital and strengthens the company's resources, said Butler, who maintains an Outperform rating and $153 price target on Esperion shares.
06/27/19
JEFF
06/27/19
NO CHANGE
Target $85
JEFF
Buy
Esperion funding agreement brings flexibility into 2020, says Jefferies
Esperion's debt financing brings in an immediate $125M, lifting the company's total pro-forma cash to $355M, and gives it flexibility going into 2020, Jefferies analyst Michael Yee tells investors in a research note. The analyst views the deal as a non-dilutive, "fundamentally good access to cash," that helps shore up Esperion's balance sheet "in case of uncertainty and macro risk in 2020." He keeps a Buy rating on the shares with an $85 price target.
09/16/19
GSCO
09/16/19
UPGRADE
Target $45
GSCO
Neutral
Esperion upgraded to Neutral from Sell at Goldman Sachs
Goldman Sachs analyst Paul Choi upgraded Esperion to Neutral from Sell but lowered his price target on the shares to $45 from $55, stating that he now sees less risk of the launch performance of bempedoic acid disappointing over the intermediate term since 2019-2022 consensus revenue estimates have come down "meaningfully." His product revenue estimates are mostly unchanged, but Choi has increased his launch related cost assumptions and slightly delayed R&D costs related to development of bempedoic acid in diabetics, the analyst noted in explaining his change in price target.
05/29/19
GSCO
05/29/19
DOWNGRADE
Target $50
GSCO
Sell
Esperion downgraded to Sell from Neutral at Goldman Sachs
Goldman Sachs analyst Paul Choi downgraded Esperion Therapeutics to Sell from Neutral with an unchanged price target of $50. With the regulatory path for bempedoic acid "looking clear," the analyst downgrades the shares on valuation following the recent outperformance. He sees the launch in 2020 as the next driver of the stock.

TODAY'S FREE FLY STORIES

03:15
10/21/19
10/21
03:15
10/21/19
03:15
General news
FX Action: USD-CAD posted a fresh two-and-a-half-month low »

FX Action: USD-CAD posted…

03:00
10/21/19
10/21
03:00
10/21/19
03:00
General news
Asian Market Update: »

Asian Market Update: It…

EDPFY

Energias de Portugal

$0.00

(0.00%)

19:56
10/20/19
10/20
19:56
10/20/19
19:56
Upgrade
Energias de Portugal rating change at JPMorgan »

Energias de Portugal…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Oct

ARWR

Arrowhead

$35.98

-0.63 (-1.72%)

19:54
10/20/19
10/20
19:54
10/20/19
19:54
Recommendations
Arrowhead analyst commentary at Piper Jaffray »

Arrowhead price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BA

Boeing

$344.09

-25.04 (-6.78%)

, FB

Facebook

$185.96

-4.435 (-2.33%)

19:31
10/20/19
10/20
19:31
10/20/19
19:31
Hot Stocks
Fly Intel: Top five weekend stock stories »

Catch up on the…

BA

Boeing

$344.09

-25.04 (-6.78%)

FB

Facebook

$185.96

-4.435 (-2.33%)

T

AT&T

$38.46

0.64 (1.69%)

CMCSA

Comcast

$45.58

-0.36 (-0.78%)

CMCSK

Comcast

$0.00

(0.00%)

DIS

Disney

$130.91

-1.46 (-1.10%)

NFLX

Netflix

$275.40

-17.88 (-6.10%)

AMZN

Amazon.com

$1,757.77

-30.07 (-1.68%)

COP

ConocoPhillips

$53.99

-0.55 (-1.01%)

GMVHF

GVC Holdings

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 23

    Oct

  • 23

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 27

    Oct

  • 28

    Oct

  • 29

    Oct

  • 29

    Oct

  • 29

    Oct

  • 30

    Oct

  • 07

    Nov

  • 18

    Nov

  • 19

    Nov

  • 19

    Nov

  • 21

    Nov

CPTA

Capitala Finance

$9.11

0.13 (1.45%)

19:23
10/20/19
10/20
19:23
10/20/19
19:23
Downgrade
Capitala Finance rating change at Keefe Bruyette »

Capitala downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Nov

GM

General Motors

$36.19

-0.01 (-0.03%)

, F

Ford

$9.29

0.18 (1.98%)

19:13
10/20/19
10/20
19:13
10/20/19
19:13
Periodicals
GM contract terms may be hard for rivals, NY Times says »

General Motors (GM) made…

GM

General Motors

$36.19

-0.01 (-0.03%)

F

Ford

$9.29

0.18 (1.98%)

FCAU

Fiat Chrysler

$13.22

0.085 (0.65%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 29

    Oct

TRI

Thomson Reuters

$66.73

-0.08 (-0.12%)

19:09
10/20/19
10/20
19:09
10/20/19
19:09
Hot Stocks
Thomson Reuters issues statement on CEO succession planning »

Thomson Reuters has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Oct

T

AT&T

$38.46

0.64 (1.69%)

, CMCSA

Comcast

$45.58

-0.36 (-0.78%)

16:45
10/20/19
10/20
16:45
10/20/19
16:45
On The Fly
Box Office Battle: 'Maleficent 2' wins weekend with just $36M »

"Box Office Battle" is…

T

AT&T

$38.46

0.64 (1.69%)

CMCSA

Comcast

$45.58

-0.36 (-0.78%)

CMCSK

Comcast

$0.00

(0.00%)

SNE

Sony

$59.23

-0.83 (-1.38%)

LGF.A

Lionsgate

$8.47

-0.13 (-1.51%)

LGF.B

Lionsgate

$7.96

-0.11 (-1.36%)

DIS

Disney

$130.91

-1.46 (-1.10%)

VIAB

Viacom

$22.05

-0.56 (-2.48%)

VIA

Viacom

$24.80

-0.8 (-3.13%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 27

    Oct

  • 28

    Oct

  • 29

    Oct

  • 30

    Oct

  • 07

    Nov

  • 07

    Nov

  • 07

    Nov

  • 14

    Nov

  • 14

    Nov

  • 18

    Nov

  • 19

    Nov

FB

Facebook

$185.96

-4.435 (-2.33%)

16:16
10/20/19
10/20
16:16
10/20/19
16:16
Periodicals
Facebook open to currency-pegged stablecoins, Reuters reports »

Facebook, facing growing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 27

    Oct

  • 30

    Oct

WYNN

Wynn Resorts

$113.55

-0.49 (-0.43%)

16:12
10/20/19
10/20
16:12
10/20/19
16:12
Periodicals
Ex-Wynn Resorts worker claims company spied on him, WSJ reports »

A former Wynn Resorts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SFTBY

SoftBank

$0.00

(0.00%)

, SFTBF

SoftBank

$0.00

(0.00%)

16:01
10/20/19
10/20
16:01
10/20/19
16:01
Periodicals
SoftBank seeking to avoid WeWork's liabilities with new investment, Reuters says »

SoftBank (SFTBY) is…

SFTBY

SoftBank

$0.00

(0.00%)

SFTBF

SoftBank

$0.00

(0.00%)

WE

We Company

$0.00

(0.00%)

JPM

JPMorgan

$120.60

0.21 (0.17%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

  • 04

    Nov

  • 06

    Nov

  • 21

    Nov

  • 14

    Jan

GM

General Motors

$36.19

-0.01 (-0.03%)

15:53
10/20/19
10/20
15:53
10/20/19
15:53
Periodicals
GM strike continues, pain felt by Midwest workers deepens, WSJ says »

With the strike at…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

BA

Boeing

$344.09

-25.04 (-6.78%)

15:43
10/20/19
10/20
15:43
10/20/19
15:43
Periodicals
Boeing expresses regret over ex-pilot's 737 Max messages, Reuters says »

Boeing said that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

ED

Consolidated Edison

$91.54

0.22 (0.24%)

, MA

MasterCard

$270.90

-5.74 (-2.07%)

15:38
10/20/19
10/20
15:38
10/20/19
15:38
Hot Stocks
MasterCard expands Bill Pay Exchange partners »

Mastercard (MA) has…

ED

Consolidated Edison

$91.54

0.22 (0.24%)

MA

MasterCard

$270.90

-5.74 (-2.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

  • 29

    Oct

  • 29

    Oct

  • 10

    Nov

  • 10

    Nov

  • 12

    Nov

LAZ

Lazard

$37.09

0.06 (0.16%)

15:33
10/20/19
10/20
15:33
10/20/19
15:33
Hot Stocks
Lazard announces resignation of Deputy CEO of Financial Advisory »

Lazard announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Oct

  • 07

    Nov

  • 07

    Nov

ALXN

Alexion

$98.41

-1.53 (-1.53%)

15:25
10/20/19
10/20
15:25
10/20/19
15:25
Hot Stocks
Alexion ULTOMIRIS receives FDA approval for Atypical Hemolytic Uremic Syndrome »

Alexion Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 04

    Nov

  • 07

    Dec

BRBR

BellRing Brands

$16.65

-0.04 (-0.24%)

, POST

Post Holdings

$100.65

-0.8 (-0.79%)

09:49
10/20/19
10/20
09:49
10/20/19
09:49
On The Fly
Opening Day: BellRing climbs after $480M IPO »

BellRing Brands (BRBR)…

BRBR

BellRing Brands

$16.65

-0.04 (-0.24%)

POST

Post Holdings

$100.65

-0.8 (-0.79%)

IPHA

Innate Pharma

$6.05

0.19 (3.24%)

KRAT

Karat Packaging

$0.00

(0.00%)

ONEW

OneWater Marine

$0.00

(0.00%)

BRP

BRP Group

$0.00

(0.00%)

PGNY

Progyny

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Oct

  • 22

    Oct

  • 23

    Oct

  • 24

    Oct

  • 07

    Dec

  • 24

    Oct

  • 24

    Oct

  • 25

    Oct

BA

Boeing

$344.09

-25.04 (-6.78%)

08:31
10/19/19
10/19
08:31
10/19/19
08:31
Periodicals
Boeing recovery getting 'a lot more complicated,' Barron's says »

Boeing shares fell on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

GMVHF

GVC Holdings

$0.00

(0.00%)

08:27
10/19/19
10/19
08:27
10/19/19
08:27
Periodicals
GVC Holdings looking like 'a good bet,' Barron's says »

GVC Holdings' stock…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EYE

National Vision

$22.98

-0.94 (-3.93%)

08:19
10/19/19
10/19
08:19
10/19/19
08:19
Periodicals
Street sees National Vision as a buy, some shorts disagree, Barron's says »

National Vision has been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CI

Cigna

$167.11

2.3 (1.40%)

, HUM

Humana

$289.59

4 (1.40%)

08:13
10/19/19
10/19
08:13
10/19/19
08:13
Periodicals
Healthcare stocks getting 'back on their feet,' Barron's says »

The sector is the second…

CI

Cigna

$167.11

2.3 (1.40%)

HUM

Humana

$289.59

4 (1.40%)

UNH

UnitedHealth

$245.59

1.84 (0.75%)

WCG

WellCare

$274.54

0.09 (0.03%)

HNT

Health Net

$0.00

(0.00%)

MOH

Molina Healthcare

$123.03

1.47 (1.21%)

TEVA

Teva

$7.50

-0.26 (-3.35%)

AZN

AstraZeneca

$43.86

-0.25 (-0.57%)

BMY

Bristol-Myers

$53.02

0.6 (1.14%)

LLY

Eli Lilly

$108.68

0.24 (0.22%)

GSK

GlaxoSmithKline

$42.52

0.04 (0.09%)

JNJ

Johnson & Johnson

$127.73

-8.47 (-6.22%)

MRK

Merck

$84.68

0.88 (1.05%)

NVS

Novartis

$86.86

-0.395 (-0.45%)

PFE

Pfizer

$36.46

(0.00%)

RHHBY

Roche

$0.00

(0.00%)

SNY

Sanofi

$46.13

-0.43 (-0.92%)

ANTM

Anthem

$249.55

0.3 (0.12%)

CVS

CVS Health

$66.17

-0.31 (-0.47%)

CNC

Centene

$46.92

-0.28 (-0.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 22

    Oct

  • 22

    Oct

  • 23

    Oct

  • 23

    Oct

  • 23

    Oct

  • 24

    Oct

  • 25

    Oct

  • 28

    Oct

  • 29

    Oct

  • 29

    Oct

  • 29

    Oct

  • 30

    Oct

  • 30

    Oct

  • 30

    Oct

  • 31

    Oct

  • 31

    Oct

  • 31

    Oct

  • 31

    Oct

  • 04

    Nov

  • 06

    Nov

  • 06

    Nov

  • 06

    Nov

  • 07

    Nov

  • 07

    Nov

  • 08

    Nov

  • 13

    Nov

  • 14

    Nov

  • 18

    Nov

  • 07

    Dec

  • 24

    Jan

  • 24

    Jan

  • 14

    Mar

COP

ConocoPhillips

$53.99

-0.55 (-1.01%)

08:03
10/19/19
10/19
08:03
10/19/19
08:03
Periodicals
ConocoPhillips stock looking cheap following selloff, Barron's says »

At a time when Wall…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

  • 19

    Nov

AMZN

Amazon.com

$1,757.77

-30.07 (-1.68%)

, NFLX

Netflix

$275.40

-17.88 (-6.10%)

08:00
10/19/19
10/19
08:00
10/19/19
08:00
Periodicals
Comcast stacking up better than investors might expect, Barron's says »

If cord-cutting…

AMZN

Amazon.com

$1,757.77

-30.07 (-1.68%)

NFLX

Netflix

$275.40

-17.88 (-6.10%)

CMCSK

Comcast

$0.00

(0.00%)

CMCSA

Comcast

$45.58

-0.36 (-0.78%)

T

AT&T

$38.46

0.64 (1.69%)

DIS

Disney

$130.91

-1.46 (-1.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 27

    Oct

  • 28

    Oct

  • 29

    Oct

  • 29

    Oct

  • 07

    Nov

  • 18

    Nov

  • 19

    Nov

  • 21

    Nov

AKS

AK Steel

$2.45

0.055 (2.30%)

, MT

ArcelorMittal

$14.58

0.03 (0.21%)

07:41
10/19/19
10/19
07:41
10/19/19
07:41
On The Fly
Week in Review: How Trump's policies moved stocks »

Catch up on the top…

AKS

AK Steel

$2.45

0.055 (2.30%)

MT

ArcelorMittal

$14.58

0.03 (0.21%)

NUE

Nucor

$51.69

-0.11 (-0.21%)

STLD

Steel Dynamics

$28.71

-0.04 (-0.14%)

TMST

TimkenSteel

$5.42

-0.015 (-0.28%)

X

U.S. Steel

$10.72

0.1 (0.94%)

GM

General Motors

$36.19

-0.01 (-0.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 29

    Oct

  • 31

    Oct

  • 01

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.